Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05989568 · ClinicalTrials.gov registry record · NA

BASIS-T Efficacy Trial

A NA study of Behavior, Child, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
276
Enrollment target
1
Study location

NCT05989568: Recruiting NA study of Behavior, Child, sponsored by University of Washington.

NCT05989568 is a NA study of Behavior, Child that is actively recruiting participants, run by University of Washington. The registered enrollment target is 276 participants, below the 894-participant average among 5 other Behavior, Child trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05989568, a NA study of Behavior, Child, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
276 participants
Enrollment target
1
Study location

Study Summary

For the approximately one in five children with social, emotional, and behavioral (SEB) challenges, accessible evidence-based prevention practices (EBPPs) are critical. In the United States, schools are the primary service setting for children's SEB service delivery but EBPPs are rarely adopted or implemented by educators (e.g., teachers) with sufficient fidelity to see effects. Given that individual behavior change is ultimately required for successful implementation, focusing on individual-level processes holds promise as a parsimonious approach to enhance adoption. Beliefs and Attitudes for Successful Implementation in Schools for Teachers (BASIS-T) is a pragmatic, multifaceted pre-implementation strategy targeting volitional and motivational mechanisms of educators' behavior change to enhance implementation and student SEB outcomes. This study protocol describes a hybrid type 3 effectiveness-implementation trial designed to evaluate the main effects, mediators, and moderators of the BASIS-T implementation strategy in the context of Positive Greetings at the Door (PGD), a universal school-based EBPP previously demonstrated to reduce student disruptive behavior and increase academic engagement.

Primary Outcome

Evidence-Based Attitudes Scale - a 15-item tool that captures attitudes toward evidence-based practices. The scale includes internally consistent scores including total score and subscale scores: (1) appeal of EBP, (2) openness to new practices, (3) likelihood of adopting an evidence-based practice, and (4) perceived divergence between current and evidence-based practices. Minimum Score 0, Maximum Score 4. Higher Scores mean better outcome.

Conditions Studied

Interventions

  • BEHAVIORAL BASIS-T
  • BEHAVIORAL Attention Control (ACC)

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2023-08-08
Est. Completion 2026-07-31
Phase NA
University of Washington

1,048 total trials

What NCT05989568 shows while recruiting

NCT05989568 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 894-participant average among 5 other Behavior, Child trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Behavior, Child appearing as the primary indexed condition, and to 2 interventions - of which BASIS-T is the first listed.

NCT05989568 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT05989568 about?

NCT05989568 is a clinical study titled "BASIS-T Efficacy Trial". For the approximately one in five children with social, emotional, and behavioral (SEB) challenges, accessible evidence-based prevention practices (EBPPs) are critical. In the United States, schools are the primary service setting for children's SEB service delivery but EBPPs are rarely adopted or i...

What is the current status of trial NCT05989568?

This trial is currently recruiting. It is a NA study. The enrollment target is 276 participants. The study started on 2023-08-08. Estimated completion is 2026-07-31.

What conditions does trial NCT05989568 study?

This clinical trial studies the following conditions: Behavior, Child.

What interventions are being tested in trial NCT05989568?

The interventions under investigation include: BASIS-T (BEHAVIORAL), Attention Control (ACC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05989568?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05989568 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Behavior, Child

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01371630 · 276 participants · Phase 1

    Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

  • NCT04192344 · 276 participants · Phase 1

    A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

  • NCT05294991 · 276 participants · NA

    Wellness App for Sleep Disturbance in Hematological Cancer Patients

  • NCT05610852 · 276 participants · NA

    Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05989568, the US trial registry maintained by the National Library of Medicine. NCT05989568 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.